Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Netrin receptor UNC5B is a transmembrane protein belonging to the UNC5 family, characterized as a dependence receptor that regulates cell survival based on ligand availability. In the presence of its primary ligand, Netrin-1, UNC5B provides survival signals; however, in the absence of Netrin-1, the receptor is cleaved by caspases to induce apoptosis [UniProt: Q8IZJ1]. This mechanism is a critical tumor-suppressive pathway that is often bypassed in various cancers through the overexpression of Netrin-1, which prevents UNC5B-mediated cell death [PubMed: 24507156]. Beyond oncology, UNC5B plays a pivotal role in the vascular system by acting as a repulsive receptor for Netrin-1 to control endothelial tip cell guidance and vessel branching [PubMed: 15510150]. It also functions in the immune system by inhibiting the migration of leukocytes, thereby acting as an endogenous anti-inflammatory signal [PubMed: 19116665]. Therapeutic development focuses on using monoclonal antibodies like NP137 to disrupt the Netrin-1/UNC5B interaction, effectively re-engaging the apoptotic program in malignant cells [PubMed: 37532831]. Consequently, UNC5B represents a versatile target for treating advanced solid tumors and potentially managing pathological angiogenesis.
Blockade of the Netrin-1/UNC5B interaction using monoclonal antibodies to trigger the dependence receptor-mediated apoptotic pathway in cancer cells [PubMed: 37532831].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Netrin receptor UNC5B (UNC5B).